Risk of the Development of Fibrosis in Metabolic Dysfunction-Associated Fatty Liver Disease in Patients with Rheumatoid Arthritis
Introduction: Individuals diagnosed with rheumatoid arthritis (RA) face a heightened risk of developing metabolic dysfunction-associated fatty liver disease (MAFLD). The primary objective of this study was to examine the progression of hepatic fibrosis through non-invasive tests in patients with MAF...
Main Authors: | Murat Aydın, Berrin Aksakal, Sema Basat |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Yayinevi
2023-11-01
|
Series: | İstanbul Medical Journal |
Subjects: | |
Online Access: |
http://istanbulmedicaljournal.org/archives/archive-detail/article-preview/risk-of-the-development-of-fibrosis-in-metabolic-d/63653
|
Similar Items
-
A Noninvasive Scoring System for Liver Fibrosis in Patients With Metabolic Dysfunction-Associated Fatty Liver Disease
by: Moniyka Sachar, et al.
Published: (2022-01-01) -
A screening study of high-risk groups for liver fibrosis in patients with metabolic dysfunction-associated fatty liver disease
by: Guanqun Chao, et al.
Published: (2024-10-01) -
Comparison of fibrosis-4 index and severity of hepatic fibrosis by fibroscan in rheumatoid arthritis patients under treatment with methotrexate
by: Majid Salmanian Mashhadi, et al.
Published: (2024-06-01) -
Transcription factors, metabolic dysfunction-associated fatty liver disease, and therapeutic implications
by: Shuwei Hu, et al.
Published: (2025-05-01) -
Copy number variation and expression of exportin-4 associates with severity of fibrosis in metabolic associated fatty liver disease
by: Mayada Metwally, et al.
Published: (2021-08-01)